Speaker illustration

Associate Professor Tarik Kivrak

Firat University, Elazig (Türkiye)

Member of:

European Society of Cardiology
Heart Failure Association

Name Surname: Tarik Kivrak Address: Firat University Hospital, Cardiology Department, Elazig, Turkey Phone: (+90 0505 372 99 45) E-Mail: tarikkivrak@gmail.com Born: July 8, 1982 – Adana-Turkey Education: Ondokuz Mayıs University Medical School, Samsun, Turkey (2000-2006). Marmara University Medical School, Cardiology Education, İstanbul, Turkey(2008-2013)(Medical Doctor), Sivas Numune Hospital, Cardiology Specialist, Sivas, Turkey(2013-2017)(Cardiology Specialist), University of Firat, Department of Cardiology, Elazig, Turkey(2017-Now)(Ass.Prof), Alma Mater Studiorum Universita Di Bologna, Pulmonary Vascular Disease, Master Degree Programme, Bologna, Italy(2018-2019) My Clinical Interests: Pulmonary Arterial Hypertension, Chronic Pulmonary Thromboembolism, Heart Failure , Artificial Intelligence My Association Membership : European Society of Cardiology, ESC Heart Failure Association, Turkish Society of Cardiology, Cardiovascular Academy Association, Lung-Vessel Diseases Ass

Pulmonary hypertension classification based on machine learning using standart chest X-ray:ATA artificial intelligence study-1

Event: Heart Failure 2023

Topic: Pulmonary Hypertension

Session: ePosters in valvular and pulmonary 3

Thumbnail

Artificial intelligence for prediction of pulmonary arterial hypertension detection using computer tomography

Event: Heart Failure 2021

Topic: Pulmonary Hypertension

Session: Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure and Hypertension

Thumbnail

The prevalence and clinical features of atrial fibrillation in heart failure patients with midrange ejection fraction in the Turkish population

Event: Heart Failure 2021

Topic: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)

Session: ePoster session

Thumbnail

Acute Effect of Sacubitril/Valsartan on Depression Score in patients with Acute Decompansed Heart Failure on the First Day of Theraphy:A Prospective Analysis from Our Center Experiences

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Thumbnail

Review of the protective effects of Compound 21 and valsartan in iso-induced heart failure in rats

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Basic science - Cardiomyopathies

Thumbnail

The rates of use of drugs that reduce mortality in patients with reduced ejection fraction in turkish population

Event: Heart Failure 2018

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Effect of Low-Dose Dopamine on Depression of Patients with Heart Failure in Coronary Intensive Unit

Event: Heart Failure 2018

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb